litlas
Log inCreate account

Dharminder Chauhan

Active 1992–2024

156
Papers
33,126
Citations
108
h-index
156
i10-index

Citations

Citations per year for Dharminder Chauhan1986: 1 citations1987: 1 citations1988: 1 citations1989: 6 citations1990: 8 citations1991: 4 citations1992: 4 citations1993: 7 citations1994: 10 citations1995: 8 citations1996: 8 citations1997: 24 citations1998: 48 citations1999: 53 citations2000: 87 citations2001: 126 citations2002: 276 citations2003: 492 citations2004: 476 citations2005: 560 citations2006: 570 citations2007: 710 citations2008: 474 citations2009: 479 citations2010: 444 citations2011: 465 citations2012: 402 citations2013: 329 citations2014: 318 citations2015: 264 citations2016: 252 citations2017: 239 citations2018: 205 citations2019: 640 citations2020: 811 citations2021: 748 citations2022: 486 citations2023: 298 citations2024: 466 citations2025: 219 citations2026: 2 citations

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 3,067 citing papers, 33.1% of this breakdownChina: 1,002 citing papers, 10.8% of this breakdownItaly: 532 citing papers, 5.8% of this breakdownUnited Kingdom: 492 citing papers, 5.3% of this breakdownGermany: 484 citing papers, 5.2% of this breakdownFrance: 304 citing papers, 3.3% of this breakdownJapan: 271 citing papers, 2.9% of this breakdownSpain: 235 citing papers, 2.6% of this breakdownAustralia: 225 citing papers, 2.4% of this breakdownCanada: 222 citing papers, 2.4% of this breakdownNetherlands: 188 citing papers, 2% of this breakdownIndia: 176 citing papers, 1.9% of this breakdown
0%33.1%Other 22.3%

Institutions

Fields

  • Medicine45.9%
  • Biochemistry, Genetics and Molecular Biology42.7%
  • Immunology and Microbiology6.8%
  • Chemistry0.8%
  • Neuroscience0.7%
  • Pharmacology, Toxicology and Pharmaceutics0.6%
  • Other2.5%

Topics

  • Multiple Myeloma Research and Treatments9.3%
  • Ubiquitin and proteasome pathways6.7%
  • Protein Degradation and Inhibitors4.9%
  • Histone Deacetylase Inhibitors Research3.3%
  • Peptidase Inhibition and Analysis3.1%
  • Cell death mechanisms and regulation2.4%
  • Other70.3%

Coauthors

All papers

Open in search
  1. A Small Molecule Inhibitor of Ubiquitin-Specific Protease-7 Induces Apoptosis in Multiple Myeloma Cells and Overcomes Bortezomib Resistance

    Authors: Dharminder Chauhan, Ze Tian, Benjamin Nicholson, Suresh Kumar, Bin Zhou, Ruben D. Carrasco, Jeffrey L. McDermott, Craig A. Leach, Mariaterresa Fulcinniti, Matthew P. Kodrasov, Joseph Weinstock, William D. Kingsbury, Teru Hideshima, Parantu K. Shah, Stéphane Minvielle, Mikael Altun, Benedikt M. Kessler, Robert Z. Orlowski, Paul G. Richardson, Nikhil C. Munshi, Kenneth C. Anderson - Cancer Cell 2012 cited by 581

  2. Bortezomib Induces Anti–Multiple Myeloma Immune Response Mediated by cGAS/STING Pathway Activation

    Authors: Annamaria Gullà, Eugenio Morelli, Mehmet Samur, Cirino Botta, Teru Hideshima, Giada Bianchi, Mariateresa Fulciniti, Stefano Malvestiti, Rao Prabhala, Srikanth Talluri, Kenneth Wen, Yu‐Tzu Tai, Paul G. Richardson, Dharminder Chauhan, Tomasz Sewastianik, Ruben D. Carrasco, Nikhil C. Munshi, Kenneth C. Anderson - Blood Cancer Discovery 2021 cited by 137

  3. The proteasome and proteasome inhibitors in multiple myeloma

    Authors: Sara Gandolfi, Jacob P. Laubach, Teru Hideshima, Dharminder Chauhan, Kenneth C. Anderson, Paul G. Richardson - Cancer and Metastasis Reviews 2017 cited by 349

  4. Structure-Guided Development of a Potent and Selective Non-covalent Active-Site Inhibitor of USP7

    Authors: Ilaria Lamberto, Xiaoxi Liu, Hyuk‐Soo Seo, Nathan J. Schauer, Roxana E. Iacob, Wanyi Hu, Deepika Sharma Das, Tatiana Mikhailova, Ellen Weisberg, John R. Engen, Kenneth C. Anderson, Dharminder Chauhan, Sirano Dhe‐Paganon, Sara J. Buhrlage - Cell chemical biology 2017 cited by 188

  5. Selective USP7 inhibition elicits cancer cell killing through a p53-dependent mechanism

    Authors: Nathan J. Schauer, Xiaoxi Liu, Robert S. Magin, Laura M. Doherty, Wai Cheung Chan, Scott B. Ficarro, Wanyi Hu, Rebekka M. Roberts, Roxana E. Iacob, Björn Stolte, Andrew O. Giacomelli, Sumner Perera, Kyle T. McKay, Sarah A. Boswell, Ellen Weisberg, Arghya Ray, Dharminder Chauhan, Sirano Dhe‐Paganon, Ken C Anderson, James D. Griffin, Jianing Li, William C. Hahn, Peter K. Sorger, John R. Engen, Kimberly Stegmaier, Jarrod A. Marto, Sara J. Buhrlage - Scientific Reports 2020 cited by 123

  6. Inhibition of USP10 induces degradation of oncogenic FLT3

    Authors: Ellen Weisberg, Nathan J. Schauer, Jing Yang, Ilaria Lamberto, Laura M. Doherty, Shruti Bhatt, Atsushi Nonami, Chengcheng Meng, Anthony Letai, Renee D. Wright, Hong L. Tiv, Prafulla C. Gokhale, Maria Stella Ritorto, Virginia De Cesare, Matthias Trost, Alexandra Christodoulou, Amanda L. Christie, David M. Weinstock, Sophia Adamia, Richard M. Stone, Dharminder Chauhan, Kenneth C. Anderson, Hyuk‐Soo Seo, Sirano Dhe‐Paganon, Martin Sattler, Nathanael S. Gray, James D. Griffin, Sara J. Buhrlage - Nature Chemical Biology 2017 cited by 152

  7. Functional Interaction of Plasmacytoid Dendritic Cells with Multiple Myeloma Cells: A Therapeutic Target

    Authors: Dharminder Chauhan, Ajita Singh, Mohan Brahmandam, Ruben D. Carrasco, Madhavi Bandi, Teru Hideshima, Giada Bianchi, Klaus Podar, Yu-Tzu Tai, Constantine S. Mitsiades, Noopur Raje, David L. Jaye, Shaji Kumar, Paul G. Richardson, Nikhil C. Munshi, Kenneth C. Anderson - Cancer Cell 2009 cited by 297

  8. Thalidomide and immunomodulatory derivatives augment natural killer cell cytotoxicity in multiple myeloma

    Authors: Faith E. Davies, Noopur Raje, Teru Hideshima, Suzanne Lentzsch, Gloria Young, Yu‐Tzu Tai, Boris K. Lin, Klaus Podar, Deepak Gupta, Dharminder Chauhan, Steven P. Treon, Paul G. Richardson, Robert Schlossman, Gareth J. Morgan, George W. Muller, David Stirling, Kenneth C. Anderson - Blood 2001 cited by 905

  9. Bortezomib induces canonical nuclear factor-κB activation in multiple myeloma cells

    Authors: Teru Hideshima, Hiroshi Ikeda, Dharminder Chauhan, Yutaka Okawa, Noopur Raje, Klaus Podar, Constantine S. Mitsiades, Nikhil C. Munshi, Paul G. Richardson, Ruben D. Carrasco, Kenneth C. Anderson - Blood 2009 cited by 371

  10. A 3D‐Bioprinted Multiple Myeloma Model

    Authors: Di Wu, Zongyi Wang, Jun Li, Yan Song, Manuel Everardo Mondragón Pérez, Zixuan Wang, Xia Cao, Changliang Cao, Sushila Maharjan, Kenneth C. Anderson, Dharminder Chauhan, Yu Shrike Zhang - Advanced Healthcare Materials 2021 cited by 42

  11. Marizomib, a Proteasome Inhibitor for All Seasons: Preclinical Profile and a Framework for Clinical Trials

    Authors: Barbara C. M. Potts, M. Albitar, Kenneth C. Anderson, Stavroula Baritaki, Celia R. Berkers, Benjamin Bonavida, Joya Chandra, Dharminder Chauhan, James C. Cusack, William Fenical, Irene M. Ghobrial, M. Groll, Paul R. Jensen, Kentson Lam, G. Kenneth Lloyd, William H. McBride, David J. McConkey, Claudia P. Miller, Saskia Neuteboom, Yasuhiro Oki, Huib Ovaa, Frank Pajonk, PG Richardson, Aldo M. Roccaro, Callum M. Sloss, Matthew A. Spear, E. Valashi, Anas Younes, Michael A. Palladino - Current Cancer Drug Targets 2011 cited by 239

  12. A novel small molecule inhibitor of deubiquitylating enzyme USP14 and UCHL5 induces apoptosis in multiple myeloma and overcomes bortezomib resistance

    Authors: Ze Tian, Pádraig D’Arcy, Xin Wang, Arghya Ray, Yu‐Tzu Tai, Yiguo Hu, Ruben D. Carrasco, Paul G. Richardson, Stig Linder, Dharminder Chauhan, Kenneth C. Anderson - Blood 2013 cited by 312

  13. Immunomodulatory drug costimulates T cells via the B7-CD28 pathway

    Authors: Richard LeBlanc, Teru Hideshima, Laurence Catley, Reshma Shringarpure, Renate Burger, Nicholas Mitsiades, Constantine S. Mitsiades, P. Cheema, Dharminder Chauhan, Paul G. Richardson, Kenneth C. Anderson, Nikhil C. Munshi - Blood 2003 cited by 286

  14. Targeting PD1–PDL1 immune checkpoint in plasmacytoid dendritic cell interactions with T cells, natural killer cells and multiple myeloma cells

    Authors: Arghya Ray, Deepika Sharma Das, Yan Song, Paul G. Richardson, Nikhil C. Munshi, Dharminder Chauhan, Kenneth C. Anderson - Leukemia 2015 cited by 213

  15. A MIR17HG-derived long noncoding RNA provides an essential chromatin scaffold for protein interaction and myeloma growth

    Authors: Eugenio Morelli, Mariateresa Fulciniti, Mehmet Samur, Caroline F. Ribeiro, León Wert-Lamas, Jonathan E. Henninger, Annamaria Gullà, Anıl Aktaş Samur, Katia Todoerti, Srikanth Talluri, Woojun D. Park, Cinzia Federico, Francesca Scionti, Nicola Amodio, Giada Bianchi, Megan Johnstone, Na Liu, Doriana Gramegna, Domenico Maisano, Nicola Antonino Russo, Charles Y. Lin, Yu‐Tzu Tai, Antonino Neri, Dharminder Chauhan, Teru Hideshima, Masood A. Shammas, Pierfrancesco Tassone, Sergei Gryaznov, Richard A. Young, Kenneth C. Anderson, Carl D. Novina, Massimo Loda, Nikhil C. Munshi - Blood 2022 cited by 35

  16. Blockade of Deubiquitylating Enzyme USP1 Inhibits DNA Repair and Triggers Apoptosis in Multiple Myeloma Cells

    Authors: Deepika Sharma Das, Abhishek Das, Arghya Ray, Yan Song, Mehmet Samur, Nikhil C. Munshi, Dharminder Chauhan, Kenneth C. Anderson - Clinical Cancer Research 2017 cited by 101

  17. NF-κB as a Therapeutic Target in Multiple Myeloma

    Authors: Teru Hideshima, Dharminder Chauhan, Paul G. Richardson, Constantine S. Mitsiades, Nicholas Mitsiades, Toshiaki Hayashi, Nikhil C. Munshi, Lenny Dang, Alfredo Castro, Vito J. Palombella, Julian Adams, Kenneth C. Anderson - Journal of Biological Chemistry 2002 cited by 892

  18. Molecular sequelae of proteasome inhibition in human multiple myeloma cells

    Authors: Nicholas Mitsiades, Constantine Mitsiades, Vassiliki Poulaki, Dharminder Chauhan, Galinos Fanourakis, Xuesong Gu, Charles C. Bailey, Marie Joseph, Towia A. Libermann, Steven P. Treon, Nikhil C. Munshi, Paul G. Richardson, Teru Hideshima, Kenneth C. Anderson - National Academy of Sciences, Proceedings of the National Academy of Sciences 2002 cited by 748

  19. Anti-DKK1 mAb (BHQ880) as a potential therapeutic agent for multiple myeloma

    Authors: Mariateresa Fulciniti, Pierfrancesco Tassone, Teru Hideshima, Sonia Vallet, Puru Nanjappa, Seth A. Ettenberg, Zhenxin Shen, Nipun Patel, Yu‐Tzu Tai, Dharminder Chauhan, Constantine S. Mitsiades, Rao Prabhala, Noopur Raje, Kenneth C. Anderson, David R. Stover, Nikhil C. Munshi - Blood 2009 cited by 398

  20. Evidence for a role of the histone deacetylase SIRT6 in DNA damage response of multiple myeloma cells

    Authors: Michele Cea, Antonia Cagnetta, Sophia Adamia, Chirag Acharya, Yu‐Tzu Tai, Mariateresa Fulciniti, Hiroto Ohguchi, Aditya Munshi, Prakrati Acharya, Manoj Bhasin, Lei Zhong, Ruben D. Carrasco, Fiammetta Monacelli, Alberto Ballestrero, Paul G. Richardson, Marco Gobbi, Roberto M. Lemoli, Nikhil C. Munshi, Teru Hideshima, Alessio Nencioni, Dharminder Chauhan, Kenneth C. Anderson - Blood 2015 cited by 126

  21. In Vitro and In Vivo Antitumor Activity of a Novel Alkylating Agent, Melphalan-Flufenamide, against Multiple Myeloma Cells

    Authors: Dharminder Chauhan, Arghya Ray, Kristina Viktorsson, Jack Spira, Claudia E. Paba‐Prada, Nikhil Munshi, Paul Richardson, Rolf Lewensohn, Kenneth C. Anderson - Clinical Cancer Research 2013 cited by 99

  22. Preclinical validation of Alpha-Enolase (ENO1) as a novel immunometabolic target in multiple myeloma

    Authors: Arghya Ray, Yan Song, Ting Du, Dharminder Chauhan, Kenneth C. Anderson - Oncogene 2020 cited by 47

  23. Loss of GABARAP mediates resistance to immunogenic chemotherapy in multiple myeloma

    Authors: Annamaria Gullà, Eugenio Morelli, Megan Johnstone, Marcello Turi, Mehmet Samur, Cirino Botta, Selma Cifrić, Pietro Folino, Delaney Vinaixa, Francesca Barello, Cole Clericuzio, Vanessa Favasuli, Domenico Maisano, Srikanth Talluri, Rao Prabhala, Giada Bianchi, Mariateresa Fulciniti, Kenneth Wen, Keiji Kurata, Jiye Liu, Johany Peñailillo, Alberto Bragoni, Anna Sapino, Paul G. Richardson, Dharminder Chauhan, Ruben D. Carrasco, Teru Hideshima, Nikhil C. Munshi, Kenneth C. Anderson - Blood 2024 cited by 18

  24. A novel orally active proteasome inhibitor induces apoptosis in multiple myeloma cells with mechanisms distinct from Bortezomib

    Authors: Dharminder Chauhan, Laurence Catley, Guilan Li, Klaus Podar, Teru Hideshima, Mugdha Velankar, Constantine S. Mitsiades, Nicolas Mitsiades, Hiroshi Yasui, Anthony Letai, Huib Ovaa, Celia R. Berkers, Benjamin Nicholson, Ta‐Hsiang Chao, Saskia Neuteboom, Paul G. Richardson, Michael A. Palladino, Kenneth C. Anderson - Cancer Cell 2005 cited by 698